Related Experiment Video
Updated: Aug 7, 2026

Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
Published on: September 15, 2023
[Hypersensitivity to carboplatin. An effect of generic drugs?]
Y Gernez1, F Barlesi, P Astoul
1Faculté de Médecine, Université de la Méditerranée, Service de pneumologie-allergologie. Hôpital Sainte-Marguerite. Marseille, France.
Introduction:
Carboplatin is a chemotherapeutic agent used frequently in thoracic medicine on account of its relatively good tolerance. Nevertheless hypersensitivity reactions have been described.
Case Reports:
We report the cases of 2 patients, treated for undifferentiated bronchial carcinoma and carcinoma of the breast, presenting with hypersensitivity reactions to carboplatin developing after 6 and 8 courses respectively. The first patient presented with an irritant maculo-papular rash and the second with severe hypotension and bronchospasm. Neither of these reactions was fatal. Both of these reactions occurred when generic carboplatin was substituted for the propriety preparation.
Conclusion:
Hypersensitivity reactions to carboplatin should be recognised by respiratory physicians on account of their potential seriousness and their occurrence after several courses of treatment. This takes on particular importance at a time when plans for domiciliary treatment of patients are being considered. In addition a national survey of hypersensitivity to carboplatin should be considered by the regional drug safety centres.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Drug Interactions
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Allergic Reactions
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists